Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
systems, behavioural, and computational neuroscientists, supporting career development, mentorship, and opportunities to present research at international conferences. About You PhD in Neuroscience or a
-
and expanding team. You’ll play a key role in our success through your code, publications, and strategic promotion of our work. * PhD in Computer Science, Biomedical Informatics, Machine Learning
-
between different neuronal cell types are organized and how this organization enables the computations they perform. To do this, we combine approaches from systems and molecular neuroscience and develop new
-
. Outstanding Young Talents Positions: Hundred Talents Program A/B, Young Faculty, Full-time Researcher, Postdoctoral Fellow Requirements: Hundred Talents Program A: PhD holders with at least 2 years of research
-
these discoveries into new therapeutic strategies. Individual projects will be tailored to the candidate’s background and interests, with additional opportunities for collaborative work with the Cancer Program at
-
Foundations. 360 000 SEK each year and is taxfree. Qualifications We seek a driven and motivated bioinformatician to contribute to our research program Eligibility: A PhD (or foreign degree deemed equivalent
-
healthcare data. * A team player who thrives as a member of a highly functional cross-disciplinary team Preferred Elements * B.S, M.S., and/or PhD in Computer Science, Biomedical Informatics, Machine Learning
-
) provides an outstanding multidisciplinary environment that underpins the BHF Centre’s research strengths. SCMMS hosts more than 65 academic groups and around 400 staff and 110 PhD students, spanning
-
Bioinformatics Core and Office of AI Research, with opportunities for all fellows to develop their own computational skills). Experimental validation – evaluating RNA drug candidates using cell-based assays
-
part of the eDyNAmiC Cancer Grand Challenge. TRACERx is a UK-wide lung cancer evolution programme which started in 2014 and has to date recruited over 820 patients. It is the first longitudinal cancer